{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:46Z","timestamp":1786119646811,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/nrl.0b013e3181b46fef","type":"journal-article","created":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T07:15:37Z","timestamp":1283930137000},"page":"315-318","source":"Crossref","is-referenced-by-count":4,"title":["Rapid Progression of Amyotrophic Lateral Sclerosis in an Acromegalic Patient After Surgical Resection of a Growth Hormone-Producing Pituitary Adenoma"],"prefix":"10.1097","volume":"16","author":[{"given":"Agnes","family":"Mondok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Aranyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor G.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandor","family":"Czirjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pusztai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibolya","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoly","family":"Racz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 4","key":"R1-7-20210211","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1212\/WNL.47.6_Suppl_4.218S","article-title":"ALS.","volume":"47","author":"Jerusalem","year":"1996","journal-title":"Neurology"},{"key":"R2-7-20210211","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00415-005-0007-9","article-title":"Diagnostic investigation and multidisciplinary management in motor neuron disease.","volume":"252","author":"Rocha","year":"2006","journal-title":"J Neurol"},{"key":"R3-7-20210211","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0168-5597(97)00018-X","article-title":"Somatosensory evoked potentials by stimulation of lower limbs nerves in amyotrophic lateral sclerosis.","volume":"104","author":"Georgesco","year":"1997","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"R4-7-20210211","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0926-6410(02)00110-6","article-title":"Cognitive impairment in amyotrophic lateral sclerosis: evidence from neuropsycological investigation and event related potentials.","volume":"14","author":"Hanagasi","year":"2002","journal-title":"Cogn Brain Res"},{"key":"R5-7-20210211","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.0009-9163.2002.00001.x","article-title":"Genetic epidemiology of amyotrophic lateral sclerosis.","volume":"63","author":"Krakauer","year":"2003","journal-title":"Clin Genet"},{"key":"R6-7-20210211","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1440-1789.2004.00546.x","article-title":"Sporadic amyotrophic lateral sclerosis of long duration mimicking spinal progressive muscular atrophy exists: additional autopsy case with a clinical course of 19 years.","volume":"24","author":"Tsuchiya","year":"2004","journal-title":"Neuropathology"},{"key":"R7-7-20210211","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1212\/01.WNL.0000049472.47709.3B","article-title":"Prognosis in amyotrophic lateral sclerosis. A population based study.","volume":"60","author":"del Aguila","year":"2003","journal-title":"Neurology"},{"key":"R8-7-20210211","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/brain\/118.3.707","article-title":"Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.","volume":"118","author":"Haverkamp","year":"1995","journal-title":"Brain"},{"key":"R9-7-20210211","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00415-004-0322-6","article-title":"The future of motor neuron disease: the challange is in the genes.","volume":"251","author":"Veldink","year":"2004","journal-title":"J Neurol"},{"key":"R10-7-20210211","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0361-9230(03)00179-5","article-title":"Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals.","volume":"61","author":"Carri","year":"2003","journal-title":"Brain Res Bull"},{"key":"R11-7-20210211","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1096\/fj.03-1199fje","article-title":"Cell death in amyotrophic lateral sclerosis: interplay between neuronal and glial cells.","volume":"18","author":"Ferri","year":"2004","journal-title":"FASEB J"},{"key":"R12-7-20210211","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1212\/01.wnl.0000223353.34006.54","article-title":"Neuroprotective agents for clinical trials in ALS: a systematic assessment.","volume":"67","author":"Traynor","year":"2006","journal-title":"Neurology"},{"key":"R13-7-20210211","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/nbdi.1999.0253","article-title":"Preclinical testing of neuroprotective neurotrophic factors in a model of chronic motor neuron degeneration.","volume":"6","author":"Corse","year":"1999","journal-title":"Neurobiol Dis"},{"key":"R14-7-20210211","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1126\/science.8171331","article-title":"Neurotrophic factors enter the clinic.","volume":"264","author":"Barinaga","year":"1994","journal-title":"Science"},{"key":"R15-7-20210211","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.nbd.2004.03.001","article-title":"IGF-I prevents glutamate-induced motor neuron programmed cell death.","volume":"16","author":"Vincent","year":"2004","journal-title":"Neurobiol Dis"},{"key":"R16-7-20210211","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/jnr.20668","article-title":"Prevention of spinal motor neuron death by insulin-like growth factor-1 associating with the signal transduction systems in SODG93A transgenic mice.","volume":"82","author":"Narai","year":"2005","journal-title":"J Neurosci Res"},{"key":"R17-7-20210211","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"R18-7-20210211","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.49.6.1621","article-title":"Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS\/IGF-I Study Group.","volume":"49","author":"Lai","year":"1997","journal-title":"Neurology"},{"key":"R19-7-20210211","first-page":"173","article-title":"Pituitary hormone concentrations in cerebrospinal fluid in patients with prolactin and growth hormone-secreting tumors.","volume":"26","author":"Rolandi","year":"1982","journal-title":"J Neurosurg Sci"},{"key":"R20-7-20210211","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1515\/JPEM.1999.12.2.113","article-title":"Blood-brain barrier for human growth hormone and insulin-like growth factor-I.","volume":"12","author":"Coculescu","year":"1999","journal-title":"J Pediatr Endocrinol"},{"key":"R21-7-20210211","first-page":"772","article-title":"The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis.","volume":"40","author":"Torres-Aleman","year":"1999","journal-title":"Neurology"},{"key":"R22-7-20210211","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF01277964","article-title":"Insulin-like growth factor-1 receptors in human spinal cord: changes in amyotrophic lateral sclerosis.","volume":"97","author":"Adem","year":"1994","journal-title":"J Neural Transm Gen Sect"},{"key":"R23-7-20210211","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02816121","article-title":"Growth factor receptors in amyotrophic lateral sclerosis.","volume":"9","author":"Adem","year":"1994","journal-title":"Mol Neurobiol"},{"key":"R24-7-20210211","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF00313611","article-title":"Insulin-like and fibroblast growth factors in spinal cords, nerve roots and skeletal muscle of human controls and patients with amyotrophic lateral sclerosis.","volume":"87","author":"Kerkhoff","year":"1994","journal-title":"Acta Neuropathol"},{"key":"R25-7-20210211","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(03)12828-0","article-title":"Free insulin-like growth factor (IGF)-I and IGF binding proteins 2, 5, and 6 in spinal motor neurons in amyotrophic lateral sclerosis.","volume":"361","author":"Wilczak","year":"2003","journal-title":"Lancet"},{"key":"R26-7-20210211","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000085764","article-title":"Insulin-like growth factor system in amyotrophic lateral sclerosis.","volume":"9","author":"Wilczak","year":"2005","journal-title":"Endocr Dev"},{"key":"R27-7-20210211","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1212\/WNL.51.2.583","article-title":"A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis.","volume":"51","author":"Borasio","year":"1998","journal-title":"Neurology"},{"key":"R28-7-20210211","first-page":"CD002064","article-title":"Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis\/motor neuron disease.","author":"Mitchell","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R29-7-20210211","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1179\/016164105X39860","article-title":"Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis.","volume":"27","author":"Nagano","year":"2005","journal-title":"Neurol Res"},{"key":"R30-7-20210211","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/mus.880160608","article-title":"Recombinant growth hormone treatment of amyotrophic lateral sclerosis.","volume":"16","author":"Smith","year":"1993","journal-title":"Muscle Nerve"},{"key":"R31-7-20210211","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1523\/JNEUROSCI.21-15-05678.2001","article-title":"Circulating insulin-like growth factor-1 mediates the protective effects of physical exercise against brain insults of different etiology and anatomy.","volume":"21","author":"Carro","year":"2001","journal-title":"J Neurosci"}],"container-title":["The Neurologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00127893-201009000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:39:38Z","timestamp":1786041578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00127893-201009000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/nrl.0b013e3181b46fef","relation":{},"ISSN":["1074-7931"],"issn-type":[{"value":"1074-7931","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}